Carterra® Inc. develops highly parallel microfluidic devices for drug discovery and life science research applications. Their technology uses a network of microchannels that uniquely enable flow-based array printing of proteins and antibodies on sensor surfaces. Carterra delivers high-resolution data for critical biotherapeutics applications at throughputs 10 – 100 times faster than existing platforms, compressing months of work into days.